| Due Diligence for Asset Managers |
|---|
|
You have viewed 6 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Unicycive Therapeutics Inc | |
|---|---|
| Ticker | UNCY |
| CIK # | 0001766140 |
| CUSIP | 90466Y202 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 5150 El Camino Real, Suite A-32, Los Altos, CA 94022 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Unicycive Therapeutics Inc | 2024-03-20 | 50.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $3,500,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001766140] | 10-K | |
| [0001766140] | 10-Q | |
| [0001766140] | 3 | |
| [0001766140] | 4 | |
| [0001766140] | 8-K | |
| [0001766140] | D | |
| [0001766140] | SC 13G |
| Form 3/4/5 Filer | 2011 - 2026 |
|---|---|
| Unicycive Therapeutics Inc | |
| Gupta Shalabh K | |
| Kenkare-Mitra Sara | |
| Jermasek Douglas | |
| Townsend John | |
| Gupta Pramod | |
| Laumas Sandeep | |
| Aggarwal Gaurav | |
| Ryan John L | |
| Schiller Brigitte |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Common Stock
|
2025-08-25 | Conversion | 652,900 | ||
|
Series A-2 Prime Preferred Stock · derivative
|
2025-08-25 | Disposed to issuer | 3,199.21 | $1,000.00 | 3,199,210 |
|
Kenkare-Mitra Sara
Stock Options · derivative
|
2025-07-28 | Grant | 21,200 | $0.00 | |
|
Aggarwal Gaurav
Stock Options · derivative
|
2025-07-28 | Grant | 21,200 | $0.00 | |
|
Gupta Shalabh K
Stock Options · derivative
|
2025-07-28 | Grant | 325,000 | $0.00 | |
|
Townsend John
Stock Options · derivative
|
2025-07-28 | Grant | 10,000 | $0.00 | |
|
Gupta Pramod
Stock Options · derivative
|
2025-07-28 | Grant | 90,000 | $0.00 | |
|
Jermasek Douglas
Stock Options · derivative
|
2025-07-28 | Grant | 10,000 | $0.00 | |
|
Laumas Sandeep
Stock Options · derivative
|
2025-07-28 | Grant | 21,200 | $0.00 | |
|
Aggarwal Gaurav
Series A-2 Prime Preferred Stock · derivative
|
2025-02-18 | Disposed to issuer | 686 | $1,000.00 | 686,000 |
|
Aggarwal Gaurav
Common Stock
|
2025-02-18 | Conversion | 1,400,000 | ||
|
Aggarwal Gaurav
Common Stock
|
2024-10-09 | Conversion | 5,500,000 | ||
|
Aggarwal Gaurav
Series A-2 Prime Preferred Stock · derivative
|
2024-10-09 | Disposed to issuer | 2,695 | $1,000.00 | 2,695,000 |
|
Gupta Pramod
Stock Options · derivative
|
2024-08-12 | Grant | 81,750 | $0.00 | |
|
Townsend John
Stock Options · derivative
|
2024-08-12 | Grant | 40,256 | $0.00 | |
|
Jermasek Douglas
Stock Options · derivative
|
2024-08-12 | Grant | 81,750 | $0.00 | |
|
Gupta Shalabh K
Stock Options · derivative
|
2024-08-12 | Grant | 232,868 | $0.00 | |
|
Townsend John
Stock Options · derivative
|
2024-04-15 | Grant | 228,119 | $0.00 | |
|
Jermasek Douglas
Stock Options · derivative
|
2024-04-15 | Grant | 463,250 | $0.00 | |
|
Gupta Pramod
Stock Options · derivative
|
2024-04-15 | Grant | 463,250 | $0.00 | |
| showing 20 of 64 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 51 | 10,455,547 |
| 2025-12-31 | 35 | 8,202,723 |
| 2025-09-30 | 30 | 6,285,927 |
| 2025-06-30 | 21 | 5,144,163 |
| 2025-03-31 | 30 | 59,926,848 |
| 2024-12-31 | 32 | 61,700,962 |
| 2024-09-30 | 30 | 46,786,772 |
| 2024-06-30 | 25 | 25,287,615 |
| 2024-03-31 | 24 | 21,247,136 |
| 2023-12-31 | 17 | 16,468,852 |
| 2023-09-30 | 17 | 14,192,814 |
| 2023-06-30 | 16 | 1,094,487 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 0 | 19,948 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 75 | 75 | Prev | Page 1 | Next |